These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
496 related articles for article (PubMed ID: 26835715)
1. Tumor Selective Silencing Using an RNAi-Conjugated Polymeric Nanopharmaceutical. Svenson S; Case RI; Cole RO; Hwang J; Kabir SR; Lazarus D; Lim Soo P; Ng PS; Peters C; Shum P; Sweryda-Krawiec B; Tripathi S; van der Poll D; Eliasof S Mol Pharm; 2016 Mar; 13(3):737-47. PubMed ID: 26835715 [TBL] [Abstract][Full Text] [Related]
2. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy. Xu C; Liu W; Hu Y; Li W; Di W Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871 [TBL] [Abstract][Full Text] [Related]
3. Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid). Wang G; Chen Y; Wang P; Wang Y; Hong H; Li Y; Qian J; Yuan Y; Yu B; Liu C Acta Biomater; 2016 Jan; 29():248-260. PubMed ID: 26476340 [TBL] [Abstract][Full Text] [Related]
4. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells. Heo MB; Cho MY; Lim YT Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635 [TBL] [Abstract][Full Text] [Related]
5. Polymeric nanoparticles for siRNA delivery and gene silencing. Patil Y; Panyam J Int J Pharm; 2009 Feb; 367(1-2):195-203. PubMed ID: 18940242 [TBL] [Abstract][Full Text] [Related]
6. Biodegradable Film for the Targeted Delivery of siRNA-Loaded Nanoparticles to Vaginal Immune Cells. Gu J; Yang S; Ho EA Mol Pharm; 2015 Aug; 12(8):2889-903. PubMed ID: 26099315 [TBL] [Abstract][Full Text] [Related]
7. SiRNA drug delivery by biodegradable polymeric nanoparticles. Yuan X; Li L; Rathinavelu A; Hao J; Narasimhan M; He M; Heitlage V; Tam L; Viqar S; Salehi M J Nanosci Nanotechnol; 2006; 6(9-10):2821-8. PubMed ID: 17048488 [TBL] [Abstract][Full Text] [Related]
8. Prolonged gene silencing by siRNA/chitosan-g-deoxycholic acid polyplexes loaded within biodegradable polymer nanoparticles. Lee JY; Lee SH; Oh MH; Kim JS; Park TG; Nam YS J Control Release; 2012 Sep; 162(2):407-13. PubMed ID: 22800573 [TBL] [Abstract][Full Text] [Related]
9. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Hadinoto K; Sundaresan A; Cheow WS Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180 [TBL] [Abstract][Full Text] [Related]
10. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy. Li TS; Yawata T; Honke K Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005 [TBL] [Abstract][Full Text] [Related]
11. Self-assembled siRNA-PLGA conjugate micelles for gene silencing. Lee SH; Mok H; Lee Y; Park TG J Control Release; 2011 May; 152(1):152-8. PubMed ID: 21185893 [TBL] [Abstract][Full Text] [Related]
12. siRNA-chitosan complexes in poly(lactic-co-glycolic acid) nanoparticles for the silencing of aquaporin-1 in cancer cells. Stigliano C; Aryal S; de Tullio MD; Nicchia GP; Pascazio G; Svelto M; Decuzzi P Mol Pharm; 2013 Aug; 10(8):3186-94. PubMed ID: 23789777 [TBL] [Abstract][Full Text] [Related]
13. Polymeric nanoparticles of siRNA prepared by a double-emulsion solvent-diffusion technique: Physicochemical properties, toxicity, biodistribution and efficacy in a mammary carcinoma mice model. Ben David-Naim M; Grad E; Aizik G; Nordling-David MM; Moshel O; Granot Z; Golomb G Biomaterials; 2017 Nov; 145():154-167. PubMed ID: 28863309 [TBL] [Abstract][Full Text] [Related]
14. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach. Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the physicochemical properties and the biocompatibility of polyethylene glycol-conjugated gold nanoparticles: A formulation strategy for siRNA delivery. Rahme K; Guo J; Holmes JD; O'Driscoll CM Colloids Surf B Biointerfaces; 2015 Nov; 135():604-612. PubMed ID: 26322474 [TBL] [Abstract][Full Text] [Related]
16. Systemic delivery of therapeutic small interfering RNA using a pH-triggered amphiphilic poly-L-lysine nanocarrier to suppress prostate cancer growth in mice. Guo J; Cheng WP; Gu J; Ding C; Qu X; Yang Z; O'Driscoll C Eur J Pharm Sci; 2012 Apr; 45(5):521-32. PubMed ID: 22186295 [TBL] [Abstract][Full Text] [Related]
17. Improvement of therapeutic efficacy of PLGA nanoformulation of siRNA targeting anti-apoptotic Bcl-2 through chitosan coating. Jagani HV; Josyula VR; Palanimuthu VR; Hariharapura RC; Gang SS Eur J Pharm Sci; 2013 Mar; 48(4-5):611-8. PubMed ID: 23291045 [TBL] [Abstract][Full Text] [Related]
18. Tumor acidity-sensitive linkage-bridged block copolymer for therapeutic siRNA delivery. Xu CF; Zhang HB; Sun CY; Liu Y; Shen S; Yang XZ; Zhu YH; Wang J Biomaterials; 2016 May; 88():48-59. PubMed ID: 26945455 [TBL] [Abstract][Full Text] [Related]
19. PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer in vitro and in vivo. Pan X; Zhu Q; Sun Y; Li L; Zhu Y; Zhao Z; Zuo J; Fang W; Li K Int J Mol Med; 2015 Apr; 35(4):995-1002. PubMed ID: 25672594 [TBL] [Abstract][Full Text] [Related]
20. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery. Gupta M; Chashoo G; Sharma PR; Saxena AK; Gupta PN; Agrawal GP; Vyas SP Mol Pharm; 2014 Mar; 11(3):697-715. PubMed ID: 24512060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]